{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:01:10Z","timestamp":1792101670314,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.brainresbull.2011.05.001","type":"journal-article","created":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T13:08:27Z","timestamp":1305205707000},"page":"380-384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease"],"prefix":"10.1016","volume":"85","author":[{"given":"Gokhan K.","family":"Ulusoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turgay","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Kayir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"G\u00fcrsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet T.","family":"Isik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayfun I.","family":"Uzbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2011.05.001_bib0005","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/1097-4547(20000615)60:6<767::AID-JNR9>3.0.CO;2-6","article-title":"Retinoic acid potentiated the protective effect of NGF against staurosporine-induced apoptosis in cultured chick neurons by increasing the trkA protein expression","volume":"60","author":"Ahlemeyer","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0166-4328(02)00180-8","article-title":"Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats","volume":"136","author":"Alam","year":"2002","journal-title":"Behav. Brain Res."},{"issue":"Suppl.","key":"10.1016\/j.brainresbull.2011.05.001_bib0015","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/nrn1434","article-title":"Oxidative stress in neurodegeneration: cause or consequence?","volume":"10","author":"Andersen","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0020","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbr.2010.07.033","article-title":"Acute but not chronic administration of pioglitazone promoted behavioral and neurochemical protective effects in the MPTP model of Parkinson's disease","volume":"216","author":"Barbiero","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0025","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(89)90291-2","article-title":"Mitochondrial function in Parkinson's disease","volume":"2","author":"Bindoff","year":"1989","journal-title":"Lancet"},{"issue":"Pt 6","key":"10.1016\/j.brainresbull.2011.05.001_bib0035","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1042\/BST0341341","article-title":"PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases","volume":"34","author":"Bordet","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0040","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1471-4159.2002.00990.x","article-title":"Protective action of the peroxime proliferators-activated receptor-\u03b3 agonist pioglitazone in a mouse model of Parkinson's disease","volume":"82","author":"Breidert","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0045","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson's disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0050","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1471-4159.2003.02210.x","article-title":"Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation","volume":"88","author":"Dehmer","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0055","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0021-9258(18)81269-8","article-title":"Differential effects of rotenone and amytal on mitochondrial electron and energy transfer","volume":"238","author":"Ernster","year":"1963","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-8993(97)00008-5","article-title":"Systemic administration of rotenone produces selective damage in the striatum and globus pallidum, but not in the substantia nigra","volume":"753","author":"Ferrante","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0065","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1093\/hmg\/ddi308","article-title":"Molecular pathogenesis of Parkinson's disease","volume":"14","author":"Gandhi","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0070","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.50.5.1346","article-title":"The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living","volume":"50","author":"Gorell","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0075","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1007\/s11064-008-9645-5","article-title":"Resveratrol protects rat striatal slices against anoxia-induced dopamine release","volume":"33","author":"G\u00fcrsoy","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0080","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1471-4159.2003.01533.x","article-title":"Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats","volume":"84","author":"H\u00f6glinger","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0085","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1471-4159.2009.06171.x","article-title":"Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF-mediated signaling","volume":"110","author":"Katsuki","year":"2009","journal-title":"J. Neurochem."},{"issue":"Suppl. 3","key":"10.1016\/j.brainresbull.2011.05.001_bib0090","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1002\/ana.10484","article-title":"Designing neuroprotection trials in Parkinson's disease","volume":"53","author":"Kieburtz","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0095","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.bbr.2008.10.010","article-title":"Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease","volume":"197","author":"Kumar","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0100","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1586\/ern.09.86","article-title":"All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease","volume":"9","author":"Lee","year":"2009","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-079X.2007.00510.x","article-title":"Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats","volume":"44","author":"Lin","year":"2008","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0115","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pharmthera.2005.08.007","article-title":"Peoxisome proliferator-activated receptors and inflammation","volume":"110","author":"Moraes","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0120","doi-asserted-by":"crossref","first-page":"42026","DOI":"10.1074\/jbc.M508628200","article-title":"Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication","volume":"280","author":"Panov","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0166-2236(03)00144-9","article-title":"The rotenone model of Parkinson's disease","volume":"26","author":"Perier","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0130","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/bjp.2008.78","article-title":"The PPAR\u03b3 agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxydase B","volume":"154","author":"Quinn","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0135","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"issue":"Suppl. 4","key":"10.1016\/j.brainresbull.2011.05.001_bib0140","first-page":"S10","article-title":"Etiology of Parkinson's disease","volume":"66","author":"Schapira","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0005-2728(01)00183-9","article-title":"Functional coupling of PSST and ND1 subunits in NADH: ubiquinone oxireductase established by photoaffinity labeling","volume":"1506","author":"Schuler","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0150","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1517\/14740331003623218","article-title":"Pioglitazone: side effect and safety profile","volume":"9","author":"Shah","year":"2010","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0155","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","article-title":"Mechanism of toxicity in rotenone models of Parkinson's disease","volume":"23","author":"Sherer","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","article-title":"Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation","volume":"179","author":"Sherer","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0165","series-title":"Animal Models of Movement Disorders","first-page":"161","author":"Sherer","year":"2005"},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0170","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.neuroscience.2007.04.032","article-title":"Retinoic acids acting through retinoid receptors protect hippocampal neurons from oxygen-glucose deprivation-mediated cell death by inhibition of c-jun-N-terminal kinase and p38 mitogen-activated protein kinase","volume":"147","author":"Shinozaki","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0175","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","article-title":"Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia","volume":"36","author":"Sian","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0180","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0185","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1517\/14728210802596906","article-title":"Parkinson's disease: emerging pharmacotherapy","volume":"13","author":"Strecker","year":"2008","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0190","series-title":"Movement Disorders: Neurologic Principles and Practise","first-page":"153","author":"Wooten","year":"1997"},{"key":"10.1016\/j.brainresbull.2011.05.001_bib0195","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/jnr.20467","article-title":"Systematic administration of iptakalim, an ATP-sensitive potassium channel opener, prevents rotenone-induced motor and neurochemical alterations in rats","volume":"80","author":"Yang","year":"2005","journal-title":"J. Neurosci. Res."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923011001444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923011001444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:11:49Z","timestamp":1759781509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923011001444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0361923011001444"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2011.05.001","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2011.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}